Not recruiting ISRCTN11790528
This study is looking at a support or therapy approach for people with depression, resistant to at least two antidepressants or Mental and Behavioural Disorders. Participants take part in the program or support approach and complete follow-up assessments.
In Finland Why is this study shown? This study is directly about Depression.
Depression Other From 18 Years to 67 Years
Countries Finland
Sponsor Hospital District of Helsinki and Uusimaa
Condition Depression Completed EUCTR 2008-004857-14
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Denmark Why is this study shown? This study is directly about Depression.
Depression, Bipolarity Biological
Countries Denmark
Sponsor Psykiatrisk Center Rigshospitalet
Condition Depression, Bipolarity Completed NCT05113771
This study is completed in the United States and in Canada. It is testing liafensine for Depression.
Multiple locations, including Huntsville Why is this study shown? This study is directly about Depression.
Depression Drug i A study involving a medication or substance. From 18 Years to 70 Years
Countries United States, Canada
Sponsor Denovo Biopharma LLC
Condition Depression Completed NCT03854578
This study is completed in Germany. It focuses on depression.
In Berlin Why is this study shown? This study is directly about Depression.
Depression Drug From 18 Years to 45 Years
Countries Germany
Sponsor Boehringer Ingelheim
Condition Depression Terminated NCT03352453
This study was terminated in the United States. It is testing rapastinel for depression.
Multiple locations, including Birmingham Why is this study shown? This study is directly about Depression.
Depression, Suicidality Drug From 18 Years to 65 Years
Countries United States
Sponsor Naurex, Inc, an affiliate of Allergan plc
Condition Depression, Suicidality Completed NCT03559192
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Tucson Why is this study shown? This study is directly about Depression.
Depression Drug From 18 Years to 64 Years
Countries United States, United Kingdom, Germany, ...
Sponsor Janssen Research & Development, LLC
Condition Depression Completed NCT06558344
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Bellflower Why is this study shown? This study is directly about Depression.
Depression Drug From 18 Years to 65 Years
Countries United States, Japan
Sponsor Boehringer Ingelheim
Condition Depression Completed NCT04521478
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Birmingham Why is this study shown? This study is directly about Depression.
Depression Drug From 18 Years to 65 Years
Countries United States, Australia, France, ...
Sponsor Boehringer Ingelheim
Condition Depression Unknown NCT04433858
This study has an unknown status in the United States. It is testing safety and Efficacy of Psilocybin for treatment-resistant depression.
Multiple locations, including Palo Alto Why is this study shown? This study is directly about Depression.
Depression Drug From 18 Years to 65 Years
Countries United States
Sponsor Sheppard Pratt Health System
Condition Depression Terminated NCT04663321
This study was terminated in the United States. It is testing MK-1942 When Added to Stable Antidepressant Therapy for treatment-resistant depression.
Multiple locations, including Birmingham Why is this study shown? This study is directly about Depression.
Depression Drug From 18 Years to 65 Years
Countries United States
Sponsor Merck Sharp & Dohme LLC
Condition Depression Completed NCT05624268
This study is completed in the United States. It focuses on Depression.
Multiple locations, including Tuscon Why is this study shown? This study is directly about Depression.
Depression Drug Over 18 Years
Countries United States
Sponsor COMPASS Pathways
Condition Depression Active Not Recruiting NCT05711940
This study is active but not recruiting in the United States, in France, in Canada, .... It focuses on Depression.
Multiple locations, including Gilbert Why is this study shown? This study is directly about Depression.
Depression Drug Over 18 Years
Countries United States, France, Canada, ...
Sponsor COMPASS Pathways
Condition Depression 
